Publications
National Hospital Cost Data Collection Private Hospital Report 2024-25
The National Hospital Cost Data Collection (NHCDC) Private Sector is a voluntary collection that produces a range of private hospital cost and activity information by the Australian Refined Diagnosis Related Groups.
Data compliance reports
The Independent Health and Aged Pricing Authority (IHACPA) publishes Data Compliance Reports including a Quarterly Report, as required by the National Health Reform Agreement (I84b).
Data Quality Framework
This Data Quality Framework has been created to enable the quality of data to be assessed, understood, communicated and managed consistently. It provides systematic and methodological rigour to IHACPA’s data quality processes at each stage of data specification, acquisi...
Aged Care Pricing Policy
The Aged Care Pricing Policy describes the principles, approach and processes that underpin the Independent Health and Aged Care Pricing Authority’s development of aged care pricing advice for residential aged care, residential respite care and in-home aged care.
Residential Aged Care Pricing Advice 2025–26
IHACPA has released the Residential Aged Care Pricing Advice 2025–26.The pricing advice informs Australian Government decisions on residential aged care funding from 1 October 2025 to 30 September 2026.
Data Access and Release Policy Version 8.0
The Independent Health and Aged Care Pricing Authority (IHACPA) is responsible for relevant data collections to enable activity based funding, as prescribed by the National Health Reform Act 2011 (the NHR Act).
National Hospital Cost Data Collection Private Sector Report 2022–23
The National Hospital Cost Data Collection (NHCDC) private sector is a voluntary collection that produces a range of hospital cost and activity information by the Australian Refined Diagnosis Related Groups.
IHACPA Strategic Plan 2025-30
The IHACPA Strategic Plan 2025–30 sets out IHACPA’s ambitious vision for the future and the steps that will be taken to achieve its goals and objectives. It reflects the agency’s commitment to investing in people, strengthening relationships across the care economy and...
High cost, highly specialised therapies
IHACPA does not have a role in the decision-making processes that inform the inclusion of a highly specialised therapy in NHRA funding arrangements.
New Health Technologies
IHACPA recognises the need for the pricing of public hospital services to respond in a timely manner to the introduction of new health technologies and innovations in models of care.